Alignment Healthcare (NASDAQ:ALHC) Price Target Raised to $25.00

Alignment Healthcare (NASDAQ:ALHC) had its price objective raised by TD Cowen from $18.50 to $25.00 in a research report report published on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Other equities research analysts also recently issued research reports about the stock. UBS Group upped their price target on shares of Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday. JPMorgan Chase & Co. raised their price objective on Alignment Healthcare from $20.00 to $23.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Piper Sandler lifted their target price on Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a report on Tuesday, January 6th. Cowen reissued a “buy” rating on shares of Alignment Healthcare in a research report on Friday. Finally, KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a report on Monday, November 24th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $21.86.

Alignment Healthcare Price Performance

NASDAQ ALHC opened at $22.50 on Friday. Alignment Healthcare has a 52 week low of $11.63 and a 52 week high of $23.19. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The company has a market capitalization of $4.50 billion, a P/E ratio of -187.50, a price-to-earnings-growth ratio of 5.92 and a beta of 1.16. The stock’s 50-day moving average price is $19.21 and its 200-day moving average price is $16.86.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The business had revenue of $993.70 million during the quarter, compared to analyst estimates of $980.90 million. During the same quarter in the prior year, the business posted ($0.14) EPS. Alignment Healthcare’s revenue for the quarter was up 43.5% compared to the same quarter last year. On average, equities research analysts predict that Alignment Healthcare will post -0.69 earnings per share for the current year.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, insider Hyong Kim sold 16,506 shares of the stock in a transaction on Tuesday, January 6th. The stock was sold at an average price of $21.35, for a total transaction of $352,403.10. Following the sale, the insider owned 333,133 shares of the company’s stock, valued at approximately $7,112,389.55. This trade represents a 4.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Robert L. Scavo sold 69,541 shares of the stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $18.74, for a total transaction of $1,303,198.34. Following the sale, the insider directly owned 503,014 shares of the company’s stock, valued at approximately $9,426,482.36. The trade was a 12.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 2,128,532 shares of company stock worth $40,979,538. Insiders own 7.00% of the company’s stock.

Institutional Investors Weigh In On Alignment Healthcare

A number of large investors have recently made changes to their positions in the stock. Larson Financial Group LLC acquired a new stake in Alignment Healthcare during the 3rd quarter worth about $33,000. SBI Securities Co. Ltd. boosted its stake in shares of Alignment Healthcare by 4,868.9% in the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after buying an additional 2,970 shares during the last quarter. GAMMA Investing LLC grew its holdings in Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after acquiring an additional 987 shares during the period. KBC Group NV purchased a new position in Alignment Healthcare during the second quarter valued at approximately $44,000. Finally, Signaturefd LLC lifted its holdings in Alignment Healthcare by 142.6% in the second quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock valued at $53,000 after acquiring an additional 2,215 shares during the period. 86.19% of the stock is owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.